Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06402123
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-05-02
Brief Title:
A Phase 2b Study of Zagociguat in Patients with MELAS
Sponsor:
Tisento Therapeutics
Organization:
Tisento Therapeutics
Organization Data
Organization:
Tisento Therapeutics
Class:
INDUSTRY
Study ID:
TIS6463-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tisento Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None